Robert Atkins
Gastroenterology · Bryn Mawr, PANPI 1023049400
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.5% of the total across 292 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $3,188 and has fallen 88.7% since, to $361 in 2025.
Across 292 payments — averaging $20.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AstraZeneca$412
- Takeda Pharmaceuticals U.S.A., Inc.$326
- Amarin Pharma, Inc.$250
- Johnson & Johnson$242
- plus $2K from 28 others
What the payments were for
- Travel & lodging$250%
- Food & beverage$5,88499%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 82 | $1,221 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 72 | $1,120 |
| AstraZeneca(2 entities) | 4 | $412 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $326 |
| Amarin Pharma, Inc. | 2 | $250 |
| Johnson & Johnson | 16 | $242 |
| Janssen Scientific Affairs, LLC | 2 | $238 |
| UCB, Inc. | 12 | $231 |
| Pfizer | 19 | $217 |
| Merck | 8 | $204 |
| QOL Medical, LLC | 9 | $131 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Paratek Pharmaceuticals, Inc. | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $120 |
| Optinose US, Inc. | 1 | $111 |
| Boehringer Ingelheim | 1 | $102 |
| Shionogi Inc | 5 | $95 |
| Bayer | 1 | $85 |
| Amgen | 1 | $78 |
| Ironwood Pharmaceuticals, Inc | 5 | $78 |
| Intercept Pharmaceuticals, Inc. | 4 | $61 |
| Daiichi Sankyo Inc. | 3 | $58 |
| Boston Scientific | 2 | $47 |
| Romark Laboratories, LC | 2 | $47 |
| Medtronic | 2 | $28 |
| Portola Pharmaceuticals, LLC | 1 | $26 |
| Gilead | 2 | $25 |
| Cumberland Pharmaceuticals, Inc. | 2 | $24 |
| Intra-sana Laboratories | 1 | $21 |
| Ferring Pharmaceuticals Inc. | 1 | $16 |
| Redhill Biopharma Inc. | 1 | $16 |
| Vivus LLC | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Lilly USA, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,916 in reported general payments places this provider in the 70th percentile of 935 gastroenterology providers in Pennsylvania.
Other gastroenterology in Bryn Mawr
- Miguel RegueiroPittsburgh$1.5M
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Sandra El-HachemPittsburgh$472K
- Harshit KharaDanville$438K
- Kofi ClarkeHershey$426K
- Michael KochmanPhiladelphia$361K
- Gary LichtensteinPhiladelphia$342K
- Elie AounPittsburgh$323K
- Andrew TinsleyHershey$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.